Comparison of BRCT domains of BRCA1 and 53BP1: A biophysical analysis

被引:17
|
作者
Ekblad, CMS
Friedler, A
Veprintsev, D
Weinberg, RL
Itzhaki, LS
机构
[1] MRC, Ctr Prot Engn, Cambridge CB2 2QH, England
[2] Dept Chem, Cambridge CB2 1EW, England
关键词
53BP1; BRCA1; BRCT; p53;
D O I
10.1110/ps.03461404
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
53BP1 interacts with the DNA-binding core domain of the tumor suppressor p53 and enhances p53-mediated transcriptional activation. The p53-binding region of 53BP1 maps to the C-terminal BRCT domains, which are homologous to those found in the breast cancer protein BRCA1 and in other proteins involved in DNA repair. Here we compare the thermodynamic behavior of the BRCT domains of 53BP1 and BRCA1 and examine their ability to interact with the p53 core domain. The free energies of unfolding are of similar magnitude, although slightly higher for 53BP1-BRCT, and both populate an aggregation-prone partly folded intermediate. Interaction studies performed in vitro by analytical size-exclusion chromatography, analytical ultracentrifugation, and isothermal titration calorimetry reveal that 53BP1-BRCT interacts with p53 with a K, in the low micromolar range. Despite their homology with 53BP1-BRCT domains, the BRCT domains of BRCA1 did not bind p53 with any detectable affinity. In summary, although other studies have indicated that the BRCT domains of both BRCA1 and 53BP1 interact with p53 core domain, the quantitative biophysical measurements performed here indicate that only 53BP1 can bind. Although both proteins may be involved in the same DNA repair pathways, our study indicates that a direct role in p53 function is unique to 53BP1.
引用
收藏
页码:617 / 625
页数:9
相关论文
共 50 条
  • [1] 53BP1 is a positive regulator of the BRCA1 promoter
    Rauch, T
    Zhong, XY
    Pfeifer, GP
    Xu, XZ
    [J]. CELL CYCLE, 2005, 4 (08) : 1078 - 1083
  • [2] Role for the BRCA1 C-terminal repeats (BRCT) protein 53BP1 in maintaining genomic stability
    Morales, JC
    Xia, ZF
    Lu, T
    Aldrich, MB
    Wang, B
    Rosales, C
    Kellems, RE
    Hittelman, WN
    Elledge, SJ
    Carpenter, PB
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (17) : 14971 - 14977
  • [3] Analysis of missense variants in BRCA1 BRCT domains
    Di Pietro, Giuliano
    Fernandes, Vanessa Camara
    Amankwah, Kwabena
    Shields, Cara
    Golubeva, Volha A.
    Harro, Carly
    Carvalho, Marcelo Alex
    Monteiro, Alvaro N.
    [J]. CANCER RESEARCH, 2017, 77
  • [4] Loss of 53BP1 Is a Gain for BRCA1 Mutant Cells
    Kass, Elizabeth M.
    Moynahan, Mary Ellen
    Jasin, Maria
    [J]. CANCER CELL, 2010, 17 (05) : 423 - 425
  • [5] Similarity trap in protein-protein interactions could be carcinogenic: Simulations of p53 core domain complexed with 53BP1 and BRCA1 BRCT domains
    Liu, Jin
    Pan, Yongping
    Ma, Buyong
    Nussinov, Ruth
    [J]. STRUCTURE, 2006, 14 (12) : 1811 - 1821
  • [6] Structure of the 53BP1 BRCT region bound to p53 and its comparison to the Brcal1 BRCT structure
    Joo, WS
    Jeffrey, PD
    Cantor, SB
    Finnin, MS
    Livingston, DM
    Pavletich, NP
    [J]. GENES & DEVELOPMENT, 2002, 16 (05) : 583 - 593
  • [7] Regulation of the BRCA1 gene by an SRC3/53BP1 complex
    Corkery, Dale
    Thillainadesan, Gobi
    Coughlan, Niamh
    Mohan, Ryan D.
    Isovic, Majdina
    Tini, Marc
    Torchia, Joseph
    [J]. BMC BIOCHEMISTRY, 2011, 12
  • [8] Cell cycle-dependent inhibition of 53BP1 signaling by BRCA1
    Feng, Lin
    Li, Nan
    Li, Yujing
    Wang, Jiadong
    Gao, Min
    Wang, Wenqi
    Chen, Junjie
    [J]. CELL DISCOVERY, 2015, 1
  • [9] Synthetic lethality and viability: how does BRCA1 interact with 53BP1?
    Morris, Jo
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2016, 159 (01) : 178 - 178
  • [10] BRCA1, PARP, and 53BP1: conditional synthetic lethality and synthetic viability
    Aly, Amal
    Ganesan, Shridar
    [J]. JOURNAL OF MOLECULAR CELL BIOLOGY, 2011, 3 (01) : 66 - 74